Free shipping on all orders over $ 500

PROTAC AR Degrader-4 TFA 

Cat. No. M31078

All AbMole products are for research use only, cannot be used for human consumption.

PROTAC AR Degrader-4 TFA  Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

PROTAC AR Degrader-4 comprises a IAP ligand binding group, a linker and an Androgen Receptor (AR) binding group. PROTAC AR Degrader-4 is an AR degrader. Degradation inducers based on cIAP1 are called specific and non-genetic IAP-dependent protein erasers (SNIPERs).

Chemical Information
Molecular Weight 884.03
Formula C45H68F3N3O11
Form Solid
Solubility (25°C) DMSO 200 mg/mL (ultrasonic)
Storage -20°C, sealed
References

[1] Deping Li, et al. Eur J Med Chem. A bibliometric analysis of PROTAC from 2001 to 2021

[2] Tingting Yao, et al. Int J Mol Sci. Recent Advances in PROTACs for Drug Targeted Protein Research

[3] Lanbo Xiao, et al. Nature. Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

[4] Weiguo Xiang, et al. J Med Chem. Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

[5] Shenxin Zeng, et al. Eur J Med Chem. Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges

Related PROTAC Products
CR8

CR8 is a potent and selective inhibitor of cyclin dependent kinase (CDK1, 2, 5, 7, and 9).

ARV-393

ARV-393 is an orally active PROTAC degrader targeting BCL6 for studies related to diffuse large B-cell lymphoma. ARV-393 utilizes the ubiquitin-proteasome system to target the degradation of BCL6.

ARV-766

ARV-766 is an orally active and potent proteolysis targeting chimera (PROTAC) protein degrader. ARV-766 degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations. ARV-766 has the potential to be first- and best-in class PROTAC AR degrader in mCRPC.

Indisulam

Indisulam is a carbonic anhydrase inibitor and antitumor CDK inhibitor. Indisulam targets the G1 phase of the cell cycle by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2, causing a blockade in the G1/S transition.

dBET6

dBET6 is a highly potent, selective and cell-permeable PROTAC connected by ligands for Cereblon and BET, with an IC50 of 14 nM, and has antitumor activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: PROTAC AR Degrader-4 TFA  supplier, PROTAC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.